skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Efficacy and safety of febuxostat extended release and immediate release in patients with gout and moderate renal impairment: phase II placebo-controlled study
Material Type:
Article
Add to My Research

Efficacy and safety of febuxostat extended release and immediate release in patients with gout and moderate renal impairment: phase II placebo-controlled study

Arthritis research & therapy, 2018-05, Vol.20 (1), p.99-99, Article 99 [Peer Reviewed Journal]

COPYRIGHT 2018 BioMed Central Ltd. ;Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2018 ;ISSN: 1478-6362 ;ISSN: 1478-6354 ;EISSN: 1478-6362 ;DOI: 10.1186/s13075-018-1593-0 ;PMID: 29848361

Full text available

2
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
Material Type:
Article
Add to My Research

Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout

The New England journal of medicine, 2018-03, Vol.378 (13), p.1200-1210 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1710895 ;PMID: 29527974

Full text available

3
Pyramid Registry: An Observational Study of Adalimumab in Crohnʼs Disease: Results at Year Five: 1682
Material Type:
Article
Add to My Research

Pyramid Registry: An Observational Study of Adalimumab in Crohnʼs Disease: Results at Year Five: 1682

The American journal of gastroenterology, 2013-10, Vol.108, p.S506 [Peer Reviewed Journal]

ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/00000434-201310001-01682

Full text available

4
Long-term Effectiveness of Adalimumab in Crohnʼs Disease: Observational Data from the PYRAMID Registry: 1804
Material Type:
Article
Add to My Research

Long-term Effectiveness of Adalimumab in Crohnʼs Disease: Observational Data from the PYRAMID Registry: 1804

The American journal of gastroenterology, 2013-10, Vol.108, p.S543-S544 [Peer Reviewed Journal]

ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/00000434-201310001-01804

Full text available

5
Induction of Remission with Adalimumab in Patients with Moderate Crohnʼs Disease: Subanalysis of CLASSIC I: 1166
Material Type:
Article
Add to My Research

Induction of Remission with Adalimumab in Patients with Moderate Crohnʼs Disease: Subanalysis of CLASSIC I: 1166

The American journal of gastroenterology, 2011-10, Vol.106, p.S436-S437 [Peer Reviewed Journal]

ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/00000434-201110002-01166

Full text available

6
Elevated C-reactive Protein in Anti-TNF-Naïve Patients is Associated with Higher Remission Rates: 1167
Material Type:
Article
Add to My Research

Elevated C-reactive Protein in Anti-TNF-Naïve Patients is Associated with Higher Remission Rates: 1167

The American journal of gastroenterology, 2011-10, Vol.106, p.S437 [Peer Reviewed Journal]

ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/00000434-201110002-01167

Full text available

7
Efficacy and Safety of Adalimumab in Moderate Compared with Severe Crohnʼs Disease: Pooled Data from the CHARM and EXTEND Trials: 1163
Material Type:
Article
Add to My Research

Efficacy and Safety of Adalimumab in Moderate Compared with Severe Crohnʼs Disease: Pooled Data from the CHARM and EXTEND Trials: 1163

The American journal of gastroenterology, 2011-10, Vol.106, p.S434-S435 [Peer Reviewed Journal]

ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/00000434-201110002-01163

Full text available

8
Baseline C-Reactive Protein is Associated With Disease Progression in Patients with Crohnʼs Disease: 1164
Material Type:
Article
Add to My Research

Baseline C-Reactive Protein is Associated With Disease Progression in Patients with Crohnʼs Disease: 1164

The American journal of gastroenterology, 2011-10, Vol.106, p.S435 [Peer Reviewed Journal]

ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/00000434-201110002-01164

Full text available

9
Risk of Malignancy, Infection, Serious Infection, and Acute Health Care Use in Patients With Crohnʼs Disease Treated With Adalimumab vs. Immunosuppressants: 1599
Material Type:
Article
Add to My Research

Risk of Malignancy, Infection, Serious Infection, and Acute Health Care Use in Patients With Crohnʼs Disease Treated With Adalimumab vs. Immunosuppressants: 1599

The American journal of gastroenterology, 2012-10, Vol.107, p.S646 [Peer Reviewed Journal]

ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/00000434-201210001-01599

Full text available

10
Foot-stabilizing shoe inserts
Material Type:
Patent
Add to My Research

Foot-stabilizing shoe inserts

Digital Resources/Online E-Resources

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (9)

Searching Remote Databases, Please Wait